Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OV101 (gaboxadol) in pediatric Angelman syndrome
NCT04106557Phase 3Completed
- Sponsor
- Healx
- Start
- Sep 2019
- Primary completion
- Nov 2020
- Modality
- Small Molecules
- Countries
- 5
01
Overview
A Phase 3 trial of gaboxadol in Angelman syndrome (AS), sponsored by Healx. Started Sep 2019; status: completed.
02
Drugs
gaboxadol
03
Conditions
Angelman syndrome (AS)
Beyond the preview
Go deeper on NCT04106557.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04106557.